[Originality of entry inhibitors].
Izopet
J
J
Service de Virologie, Hôpital Purpan, Place Du Docteur Baylac, TSA 40031, 31059 Toulouse cedex 9, France.
D065100:CCR5 Receptor Antagonists; D015704:CD4 Antigens / Q000502:physiology; D015496:CD4-Positive T-Lymphocytes / Q000821:virology; D015195:Drug Design; D005838:Genotype; D015699:HIV Envelope Protein gp120 / Q000737:chemistry / Q000502:physiology; D023581:HIV Fusion Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1 / Q000145:classification / Q000187:drug effects* / Q000235:genetics; D006801:Humans; D010446:Peptide Fragments / Q000737:chemistry / Q000502:physiology; D025941:Protein Interaction Mapping; D019713:Receptors, CCR5 / Q000502:physiology; D019718:Receptors, CXCR4 / Q000502:physiology; D056189:Viral Tropism / Q000235:genetics; D053586:Virus Internalization / Q000187:drug effects*
D065100:CCR5 Receptor Antagonists; C584933:CCR5 protein, human; D015704:CD4 Antigens; C527276:CXCR4 protein, human; D015699:HIV Envelope Protein gp120; D023581:HIV Fusion Inhibitors; C059762:HIV envelope protein gp120 (305-321); D010446:Peptide Fragments; D019713:Receptors, CCR5; D019718:Receptors, CXCR4